Patent · US Revoked

Modulation of stat5 expression

US8476421B2 · kind B2 · utility

0Cited by
14References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 22, 2010
Grant dateJul 2, 2013
Priority date
Expiry dateSep 7, 2030

Classification

  • Technology area (CPC —)General

Abstract

Compounds, compositions and methods are provided for modulating the expression of STAT5. The compositions comprise oligonucleotides, targeted to nucleic acid encoding STAT5. Methods of using these compounds for modulation of STAT5 expression and for diagnosis and treatment of diseases and conditions associated with expression of STAT5 are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.